Patents by Inventor Jeremy P. W. Heaton

Jeremy P. W. Heaton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6200983
    Abstract: Psychogenic impotence or erectile dysfunction can be identified in psychogenic male patients and can be ameliorated, without substantial undesirable side effects, by sublingual administration of apomorphine dosage forms so as to maintain a plasma concentration of apomorphine of no more than about 5.5 nanograms per milliliter.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: March 13, 2001
    Assignees: Pentech Pharmaceuticals, Inc., Queen's University at Kingston
    Inventors: Ragab El-Rashidy, Jeremy P. W. Heaton, Alvaro Morales, Michael A. Adams
  • Patent number: 6200288
    Abstract: An everting toroid for use in delivering a powdered, fluid, or aerosolized pharmaceutical composition, or other composition, to an internal body cavity, such as the urethra, or other cavity, is contained within a tubular housing and may be extended therefrom and retracted back into the tubular housing. The composition may be distributed on the surface of the everting toroid when made from an impermeable membrane, contained within the toroid when made from a permeable membrane, or may be injected through the lumen thereof via an aerosol wand which releases the composition as the toroid and/or wand are withdrawn from the cavity.
    Type: Grant
    Filed: January 29, 1999
    Date of Patent: March 13, 2001
    Assignee: Queen's University at Kingston
    Inventors: Jeremy P. W. Heaton, Michael A. Adams, James D. Banting
  • Patent number: 6165975
    Abstract: A method of treatment, in an organism, of a vascular condition, comprising administration of at least one agent at a level which enhances NO and which does not appreciably alter normal systemic vascular tone in said organism. At least one agent is an NO donor selected from the group consisting of glyceryl trinitrate, isosorbide 5-mononitrate, isosorbide dinitrate, pentaerythritol tetranitrate, erythrityl tetranitrate, sodium nitroprusside, 3-morpholinosydnonimine molsidomine, S-nitroso-N-acetylpenicillamine, S-nitrosoglutathione, and N-hydroxy-L-arginine.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: December 26, 2000
    Assignee: Queen's University at Kingston
    Inventors: Michael A. Adams, Jeremy P. W. Heaton, James D. Banting
  • Patent number: 5985889
    Abstract: Psychogenic impotence or erectile dysfunction can be identified in psychogenic male patients and can be ameliorated, without substantial undesirable side effects, by sublingual administration of apomorphine dosage forms so as to maintain a plasma concentration of apomorphine of no more than about 5.5 nanograms per milliliter.
    Type: Grant
    Filed: June 22, 1998
    Date of Patent: November 16, 1999
    Assignees: Pentech Pharmaceuticals, Inc., Queen's University at Kingston
    Inventors: Ragab El-Rashidy, Jeremy P. W. Heaton, Alvaro Morales, Michael A. Adams
  • Patent number: 5954688
    Abstract: An everting toroid for use in delivering a powdered or liquid or aerosolized drug to an internal body cavity, such as the urethra, is described. The drug may be distributed on the surface of the everting toroid or may be injected through the lumen thereof via an aerosol wand which is designed to release the drug as the toroid and/or wand are withdrawn from the body cavity.
    Type: Grant
    Filed: August 26, 1997
    Date of Patent: September 21, 1999
    Assignee: Queen's University at Kingston
    Inventors: Michael A. Adams, Jeremy P. W. Heaton, James D. Banting
  • Patent number: 5770606
    Abstract: Psychogenic impotence or erectile dysfunction can be identified in psychogenic male patients and can be ameliorated, without substantial undesirable side effects, by sublingual administration of apomorphine dosage forms so as to maintain a plasma concentration of apomorphine of no more than about 5.5 nanograms per milliliter.
    Type: Grant
    Filed: October 20, 1995
    Date of Patent: June 23, 1998
    Assignees: Pentech Pharmaceuticals, Inc., Queen's University at Kingston
    Inventors: Ragab El-Rashidy, Jeremy P. W. Heaton, Alvaro Morales, Michael A. Adams